Xiang Wang

Title: Innovations of Xiang Wang

Introduction

Xiang Wang is an accomplished inventor based in Moorpark, CA (US). He has made significant contributions to the field of chemistry, particularly in the development of compounds with therapeutic applications. With a total of 3 patents, his work has garnered attention in the scientific community.

Latest Patents

Xiang Wang's latest patents include an asymmetric process for making substituted 2-amino-thiazolones. This invention provides two processes for synthesizing substituted aminothiazolone compounds as inhibitors of 11-β-hydroxy steroid dehydrogenase type 1. The processes allow the stereoselective synthesis of the desired compounds without the use of stoichiometric amounts of chiral catalysts. Another notable patent involves naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, along with their compositions and uses. These compounds are useful as inhibitors of HIF prolyl hydroxylases, showcasing the innovative nature of his research.

Career Highlights

Xiang Wang is currently associated with Amgen Inc., a leading biotechnology company. His work at Amgen has allowed him to focus on developing novel therapeutic agents that can address various health challenges. His expertise in chemistry and innovative thinking have positioned him as a valuable asset to the company.

Collaborations

Xiang has collaborated with notable colleagues, including Jennifer Rebecca Allen and Kaustav Biswas. These collaborations have fostered a productive environment for research and development, leading to advancements in their respective fields.

Conclusion

Xiang Wang's contributions to the field of chemistry through his patents and collaborations highlight his innovative spirit and dedication to scientific advancement. His work continues to impact the development of new therapeutic agents, showcasing the importance of innovation in addressing health challenges.